|
|
Do you think the growing number of anticounterfeiting technologies, coupled with increased focus from regulators, have had a positive impact on reducing the number of counterfeit pharmaceuticals in the legal supply chain? |
|
Yes |
53% |
|
|
No |
14% |
|
|
|
|
Technologies have; regulations are still inadequate |
26% |
|
|
|
|
Regulations have; technologies are still inadequate |
7% |
This week we would like to know...
Concerns have recently been raised about the safety of confidential data at FDA. Do you think regulators are doing enough to protect confidential data?

|
|
Contact Us
Click here to contact editorial.
Click here to contact sales. |
|